Post by Oncidium foundation

What does it take for one patient's fight to spark change far beyond his own?   In our latest feature for #RadiotheranosticsToday, we trace the journey from a single life-changing treatment donation to a catalyst for systemic change.   #RLTConnect, our dose donation program, started with Fernando Acosta's fight for radioligand therapy. The barriers it revealed now drive Oncidium's push for systemic change.   It began in 2018 with Fernando Acosta, diagnosed with metastatic prostate cancer in Argentina, where 177Lu-PSMA therapy was out of reach. His determination to get access became the seed of a donation program now reaching patients across the world, the RLT-Connect.   Every RLT-Connect case highlights the deep barriers to equitable cancer care: fragmented reimbursement, market constraints, and a lack of inclusion in national formularies. Moving into our second phase of action, we are going beyond dose donations. We are actively championing the integration of RLT into healthcare systems to transform oncology and establish it as a universal standard of care    👉 Read the full edition of Radiotheranostics Today: https://lnkd.in/eieV_9ei   Thank you to the authors, Dr. Alice Viana and Elisa Cannarozzo, for sharing this story.   #Radiopharmaceuticals #PatientAccess #HealthEquity